Canadians Value Vaccines and Medicines as Helpful in Promoting Health and Reducing Health Care Costs

OTTAWA, Sept. 20, 2011 /CNW/ - Public opinion poll results released today show that Canadians believe that investment in innovative vaccines and medicines not only improve health outcomes, but contribute to a sustainable health care system and a stronger economy.

Conducted in July and early August 2011 the public opinion survey by Nanos Research of 1200 Canadians shows that 93% of respondents agree or somewhat agree that new medicines and vaccines improve the quality of life of patients.

A majority of Canadians (80%) agree or somewhat agree that new medicines and vaccines reduce costs to the health care system by reducing hospital surgeries and admissions. Over eight in ten Canadians (84%) agree or somewhat agree that public vaccination programs, increase general productivity in the workplace by reducing sickness and absenteeism.

Finally, 90% of respondents agree or somewhat agree that vaccines have the potential to save lives by addressing major public health threats.

"These results demonstrate that Canadians understand the full value brought by innovative medicines and vaccines," said Russell Williams, President of Rx&D Canada. "Canadians see the potential of vaccination programs and the role they play in terms of positive health care outcomes, savings and sustainability."

Vaccines are considered one of the most effective health interventions ever developed in the fight against disease. Many diseases are now vaccine preventable and each year vaccines save an estimated three million lives world-wide.

"The high value Canadians place on vaccines is well earned due to the role they play in keeping Canadians healthy, from preventing infectious diseases such as polio and mumps to the recent H1N1 influenza pandemic. This is why governments fund vaccination programs," said Mark Lievonen, Co-Chair of the Vaccine Industry Committee.

"Canada has been a leader in vaccines research and development, and we need to maintain that leadership position," declared Russell Williams. "It is crucial that Canada supports strong and internationally competitive intellectual property safeguards, as contemplated by the on-going CETA negotiations with the European Union, so that research is performed in our country and we make the best use of our scientific and research talent."

"It is critical that governments adopt policies that recognize the costs associated with developing innovative vaccines and the value they bring, not only to our health care system but our entire economy. With the right approach, we can provide greater hope for future generations."

Nanos Research conducted a national random telephone survey of 1,203 Canadians between July 25th and August 2nd, 2011. The margin of error for a survey of 1,203 Canadians is ± 2.8 percentage points 19 times out of 20.

The results of the National Nanos Research poll can be found at

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents 15,000 men and women working for 50 member companies and invests more than $1 billion in research and development each year to fuel Canada's knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.


For further information:

Christine Choury
Media Relations
Telephone: 613-236-0455 Ext. 831
Cell: 613 863-2120

Profil de l'entreprise


Renseignements sur cet organisme


Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .


Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.


Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.